Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
Unternehmens-codePTHL
Name des UnternehmensPheton Holdings Ltd
IPO-datumSep 05, 2024
Gegründet am2022
CEOMr. Jianfei Zhang
Anzahl der mitarbeiter10
WertpapierartOrdinary Share
GeschäftsjahresendeSep 05
AddresseRoom 306, NET Building
StadtBEIJING
BörseNASDAQ Capital Market Consolidated
LandChina
Postleitzahl100012
Telefon861084817665
Websitehttp://www.ftzy.com.cn/ir/index.php
Unternehmens-codePTHL
IPO-datumSep 05, 2024
Gegründet am2022
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten